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The lack of antifungal drugs with novel modes of action reaching the clinic is a serious
concern. Recently a novel antifungal protein referred to as Blad-containing oligomer
(BCO) has received regulatory approval as an agricultural antifungal agent. Interestingly
its spectrum of antifungal activity includes human pathogens such as Candida albicans,
however, its mode of action has yet to be elucidated. Here we demonstrate that BCO
exerts its antifungal activity through inhibition of metal ion homeostasis which results in
apoptotic cell death in C. albicans. HIP HOP profiling in Saccharomyces cerevisiae using
a panel of signature strains that are characteristic for common modes of action identified
hypersensitivity in yeast lacking the iron-dependent transcription factor Aft1 suggesting
restricted iron uptake as a mode of action. Furthermore, global transcriptome profiling
in C. albicans also identified disruption of metal ion homeostasis as a potential mode of
action. Experiments were carried out to assess the effect of divalent metal ions on the
antifungal activity of BCO revealing that BCO activity is antagonized by metal ions such
as Mn2+, Zn2+, and Fe2+. The transcriptome profile also implicated sterol synthesis
as a possible secondary mode of action which was subsequently confirmed in sterol
synthesis assays in C. albicans. Animal models for toxicity showed that BCO is generally
well tolerated and presents a promising safety profile as a topical applied agent. Given
its potent broad spectrum antifungal activity and novel multitarget mode of action, we
propose BCO as a promising new antifungal agent for the topical treatment of fungal
infections.
Keywords: Blad-containing oligomer, antifungal, metal chelation, metal homeostasis, multitarget mode of action,
toxicology
INTRODUCTION
Relative to antibacterial drug discovery, antifungal drug research has received less attention,
(Delarze and Sanglard, 2015; Ngo et al., 2016); this is despite the fact that 1.2 billion
people worldwide suffer from fungal diseases (Denning and Bromley, 2015) and mortality
rates may exceed those caused by tuberculosis or malaria (Brown et al., 2012). Unlike
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bacterial infections, which can be treated aggressively and with
few toxic side effects, the shared eukaryotic nature of fungi and
mammals presents a greater challenge when seeking selective
low toxicity candidate molecules (Geiser, 2015). The pace of
developing new antifungal drugs has been extremely slow, and
with numerous failures (Liu et al., 2016). Most new promising
compounds end up failing during the final development
stages, mostly because of their mode of action (promoting
fungal resistance) and/or toxicity issues. This low success rate
has definitely discouraged the pharmaceutical industry from
investing their resources on this type of research and explains the
absence of new drug classes since echinocandins were introduced
in 2001.
A restricted number of chemical classes are currently in
clinical use as antifungal agents (Delarze and Sanglard, 2015)
and novel resistance profiles to these drugs are frequently
reported (Papon et al., 2007; Perlin, 2007; Grossman et al.,
2015; Sanguinetti et al., 2015; Kołaczkowska and Kołaczkowski,
2016; Morschhäuser, 2016), including development of multi-drug
resistance strains (Sanglard, 2016). Only minimal resistance to
the polyene amphotericin B (AMB) has evolved despite more
than 30 years of intensive clinical use (Kanafani and Perfect, 2008;
Davis et al., 2015), probably due to its multitarget mode of action
(Gray et al., 2012). However AMB is well known for its side effects
and toxicity (Spampinato and Leonardi, 2013; Nett and Andes,
2016). A novel class of antifungal drugs, named orotomides,
is now emerging, with very promising results in dimorphic
and filamentous fungi, particularly for Aspergillus spp., and is
currently in late phase 1 clinical trials for the treatment of invasive
aspergillosis (Oliver et al., 2016). Nonetheless, it acts via a novel
mechanism of action that targets a single enzyme (inhibition of
the dihydroorotate dehydrogenase), and it has no activity against
human pathogenic yeasts (Oliver et al., 2016). Generally, drugs
acting on a single cellular target are more likely to encounter the
problem of drug resistance (Wong et al., 2014).
Recently, we reported the discovery of an edible polypeptide,
named Blad, which accumulates in Lupinus cotyledons (Monteiro
et al., 2015) and occurs naturally as part of a 210 kDa oligomer
(BCO, after Blad-containing oligomer). BCO exhibits potent
and broad-spectrum fungicidal activity, comparing favourably
to fluconazole (FLC) and AMB in in vitro (Pinheiro et al.,
2016) and surpassing some commercially available fungicides in
greenhouse and field conditions. BCO is currently on sale in the
United States, Canada, and South Korea under the trade name
FractureTM. Other certification processes are currently under way
worldwide. The highly complex and multitarget mechanism of
action of BCO (Pinheiro et al., 2016) was already aknowledged
by the Fungicide Resistance Action Committee (FRAC), with its
inclusion in a new mode of action category, M12, on the 2016
issue of the FRAC Code List© for agricultural applications.
With such a wide range of bioactivities, anyone skilled-in-the-
art would expect BCO to be toxic to mammal cells as well. In
this study, we demonstrate that this does not seem to be the case.
In addition to its inherent capacity to bind (lectin activity) and
cleave chitin (N-acetyl-D-glucosaminidase activity) (Monteiro
et al., 2015), we confirm now that BCO affects fungal cells at
several levels, and identify metal scavenging as the main mode
of action leading to apoptotic cell death. This highly complex and
multitarget mode of action, unlikely to promote fungal resistance,
combined with its natural origin and the absence of mammal
topical toxicity, or genotoxicity may constitute a stepping-stone
into a new era of clinical antifungal agents.
MATERIALS AND METHODS
Ethics Statement
All assays involving mammals were conducted in two laboratories
with GLP compliance status: Covance Laboratories (England),
and Eurofins PSL – Product Safety Labs (United States). At
Covance, the following studies were performed in accordance
with the requirements of the Animals (Scientific Procedures)
Act 1986 and all protocols were previously subjected to the site
Ethical Review Process (EPR). For the 21-day study, animal
testing was performed under the approval of the Research Ethics
Committee (UK Health Departments’ Research Ethics Service,
National Health Service, England), with the project license
number PPL 70/7602-2. At Eurofins PSL, all acute toxicological
studies were performed in accordance with the requirements of
40 CFR Part 160: U.S. EPA (FIFRA), 1989, OECD (as revised in
1997) published in ENV/MC/CHEM (98)17, OECD, Paris, 1998;
and EC Directive 2004/10/EC, Official Journal of the European
Union, L50/44, Feb. 20, 2004. EUROFINS Product Safety Labs
(PSL, United States), is AAALAC accredited, GLP compliant and
USDA registered. All protocols of the acute toxicological studies
were reviewed and unanimously approved by the Internal Animal
Care and Use Committee (IACUC) on the fourteen of May 2010:
acute dermal toxicity (PSL protocol #P322), primary eye irritation
(PSL protocol #324), dermal sensitization (PSL protocol #P328)
and primary skin irritation (PSL protocol #P326).
Microorganisms and Culture Media
Saccharomyces cerevisiae BY4743 and Candida albicans CBS 562
were grown in Glucose-Yeast extract-Peptone (GYP) medium
(0.5% w/v peptone, 0.5% w/v yeast extract, 2% w/v glucose,
and 1.5% w/v agar), for 24 h, at 30 and 34◦C, respectively.
For the assays described here, the media used were: Synthetic
Complete (SC) broth with 2% (w/v) glucose (FORMEDIUM) for
S. cerevisiae, and Potato-Dextrose-Broth (PDB, DIFCO) buffered
at pH 7.5 and Yeast extract-peptone-Dextrose medium (YPD:
2% w/v peptone, 1% w/v yeast extract, and 2% w/v glucose) for
C. albicans.
Plant Material
Lupinus albus L. seeds were purchased from Inveja SAS (France)
and were germinated and grown in growth chambers with a
photoperiod of 16 h light/8 h dark at 18◦C, for periods up to
10 days. The seed coats were removed and the intact cotyledons
were dissected from the axes and stored frozen at −80◦C until
needed.
Antifungal Agents
Blad-containing oligomer (BCO) was extracted and purified
from 8-days-old cotyledons as previously described (Monteiro
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et al., 2010) and stored lyophilized at room temperature. Stock
solutions of AMB, FLC, and caspofungin (all from SIGMA) were
prepared and stored frozen at−20◦C until used.
Global Transcriptome Profiling
The transcriptome profiling of C. albicans was analyzed by RNA-
sequencing (RNA-seq). Two cultures of C. albicans were grown
as described below in the ‘Determination of endogenous ROS
production’ section, one in the presence of BCO, and the other in
its absence (control). After 4 h of incubation, cells were harvested
and subjected to a treatment with 0.4 mg/mL lyticase in 50 mM
Tris-HCl pH 7.5, 1 M sorbitol, 0.8 M KCl, 10 mM MgSO4, and
15 mM β-mercaptoethanol for 1 h at 30◦C with gentle stirring to
digest the cell wall. Spheroplasts were pelleted by centrifugation
and their RNA extracted according to the instructions of the RNA
isolation kit (RNeasy Mini Kit – QIAGEN) and stored at−80◦C.
Poly(A) mRNA was purified from ca. 25 µg total RNA with
two rounds of Dynabeads mRNA DIRECT Micro Purification
Kit (Invitrogen). cDNA libraries were constructed with the Ion
Total RNA-Seq Kit v2 (Life Technologies) and quantified with
Agilent DNA 1000 Kit in the Agilent 2100 Bioanalyzer (Agilent
Technologies). The fragments of six barcoded libraries were
pooled and clonally amplified by emulsion PCR using the Ion PI
Template OT2 200 kit v2 and the Ion OneTouch 2 System (Life
Technologies), and the positive Ion Sphere Particles enriched
with Ion OneTouch ES (Life Technologies). This procedure was
performed twice for a total of two groups of clonally amplified
library spheres. Finally, the positive ion spheres were loaded
into two Ion PI chip v2 and sequenced in the Ion Proton
System (Life Technologies) and Ion PI Sequencing 200 Kit v2 at
Genoinseq (Biocant, Cantanhede, Portugal). Ion Proton adapter
sequences and low-quality bases were trimmed using the Torrent
Suite software (Life Technologies). Duplicate reads were removed
using PRINSEQ (Schmieder and Edwards, 2011) and rRNA reads
were removed using RiboPicker (Schmieder et al., 2012). The
remaining reads were mapped using TMAP version 4.0.6 (Life
Technologies) against the reference transcriptome of C. albicans
(genome C. albicans SC5314 A22-s06-m01-r05) (Skrzypek et al.,
2016). Read count was performed by eXpress1 for each condition
(Roberts and Pachter, 2012). Gene name and description for each
reference transcript were extracted from the Candida Genome
Database annotation files (Skrzypek et al., 2016).
Read counts were uploaded to the Degust2 and analyzed using
Limma/Voom method, which was incorporated into Degust.
Coding sequences with a false discovery rate (FDR) < 0.1 and
a fold change greater than 1, were considered significant.
S. cerevisiae HIP HOP Profiling with a
Panel of Gene Deletion Signature Strains
In this study we used S. cerevisiae as model organism, rather than
C. albicans, since this is the only yeast species for which a
complete deletion mutant strain collection exists (Giaever
and Nislow, 2014). BCO was tested on S. cerevisiae gene
deletion strains, purchased from EUROSCARF (Supplementary
1https://github.com/adarob/eXpress/
2http://www.vicbioinformatics.com/degust/
Table S1). The 27 selected strains have been previously
determined to be characteristic for common modes
of action in which a specific target protein is lacking
(Hoepfner et al., 2014) and constitute a mini HIP HOP
assay (Prescott and Panaretou, 2017). Heterozygous dip-
loids: nmd31/NMD3, rei11/REI1, lsg11/LSG1, ssl21/SSL2,
neo11/NEO1, tim541/TIM54, pik11/PIK1, cmd11/CMD1,
tda101/TDA10, mia401/MIA40, tom401/TOM40, and mrpl
191/MRPL19. Homozygous diploids: lem31/lem31, fen11/
fen11, lro11/lro11, aft11/aft11, ftr11/ftr11, ctr11/ctr11,
fet31/fet31, ire11/ire11, hac11/hac11, sur41/sur41, slt21/slt
21, aro11/aro11, trp41/trp41, bck11/bck11, and rim1011/
rim10 1. The diploids have the following isogenic background:
MATa/α; his311/his311; leu210/leu 10; met1510/MET15; LYS
2/lys210; ura310/ura310 with genes deleted with KANMX4.
Cultures of each strain were grown to late log phase and
their optical density determined with a 1 cm path length
spectrophotometer. The cultures were then adjusted to OD600
0.00015 in SC medium and transferred to a transparent
polystyrene 384 well microplate. Each microplate well contained
50 µl yeast culture in liquid SC medium with or without
BCO. The microplate with lid was then incubated at 30◦C in
a Tecan Infinite M200 plate reader recording OD600 readings
in 9 separate locations per well every 20 min between 5 and
27 h. Growth inhibition over 24 h was determined for each
strain relative to the corresponding untreated control. The same
procedure was carried out for the isogenic control strain BY4743.
Each curve is an average of 12 replicate wells.
Effect of Metallic Ions on BCO Bioactivity
To test the effect of metallic ions on BCO antifungal activity,
susceptibility tests were performed on C. albicans in the
presence of increasing concentrations of these elements.
The susceptibility tests were made according to the CLSI –
Clinical and Laboratory Standards Institute (former NCCLS –
National Committee for Clinical Laboratory Standards)
guideline M27-A2 (NCCLS, 2002), with some adjustments,
using broth microdilution method, as previously described
(Pinheiro et al., 2016). Six different cations were supplied,
separately, in the culture medium (PDB): copper (CuCl2 and
CuSO4.5H2O), calcium [CaCl2.2H2O, CaSO4 and Ca(NO3)2],
magnesium (MgCl2.10H2O and MgSO4.7H2O), iron (FeCl2 and
FeSO4.7H2O), zinc (ZnCl2 and ZnSO4.7H2O), and manganese
(ZnCl2 and ZnSO4.7H2O). Each cation was tested under different
salt forms (described above in round brackets) separately, in
order to determine any possible influence of the anion in the
results. First, the minimum toxic concentration for each of
these cations was determined with concentrations ranging from
4.88 µM to 10 mM. After determining the toxicity lower limit,
progressively lower concentrations of each cation were tested
with BCO. A culture medium without supplemented cations
and with BCO was used as control. All assays were performed
in triplicate. The content of each cation in the unsupplemented
(original) PDB medium was quantified prior to the addition
of the salts. A mixture of three different batches of PDB was
homogenized and a single analysis was performed. The mixture
was previously acid digested with micro-waves, and the content
Frontiers in Microbiology | www.frontiersin.org 3 June 2017 | Volume 8 | Article 1182
fmicb-08-01182 June 24, 2017 Time: 15:6 # 4
Pinheiro et al. Antifungal Mode of Action Blad-Containing Oligomer
of the cations was determined by inductively coupled plasma
optical emission spectrometry (ICP-OES) (ISO 11885, 2007).
Quantification of the Plasma Membrane
Ergosterol
A fresh culture of C. albicans was inoculated in 50 mL YPD
medium for 24 h at 34◦C, without shaking containing a sub-
inhibitory concentration of BCO (2.4 µM). Sub-inhibitory
concentrations of FLC (208 µM), AMB (0.27 µM), and
caspofungin (26 µM) were also tested as references of ergosterol
targeted modes of action (positive control – FLC; negative
control – caspofungin; multitarget mode of action – AMB).
Cells were harvested by centrifugation and washed with distilled
water. Total intracellular sterols were extracted and quantified as
previously described (Arthington-Skaggs et al., 1999). Statistical
analysis was performed using GraphPad Prism software version
5.02, La Jolla, CA, United States. P-values were calculated using
one-way ANOVA and Bonferroni multiple comparison post-test.
Determination of Endogenous ROS
Production
A fresh culture of C. albicans was inoculated (1 × 105 CFU/mL)
in PDB pH 7.5 with 2.4 µM BCO and incubated at 34◦C
without shaking. After 4 h incubation, intracellular reactive
oxygen species (ROS) levels were measured by a fluorometric
assay using the fluorescent dye 2,7-dichloro-dihydro-fluorescein
diacetate (DCFH-DA; Sigma) as a ROS indicator, as previously
described (Favre et al., 2008). PDB pH 7.5 was used as negative
control and PDB pH 7.5 with 20 mM H2O2 (added 30 min before
ROS analysis) as positive control.
Annexin V and PI Staining
Annexin V/propidium iodide (PI) binding assays were performed
according to the FITC Annexin V/Dead Cell Apoptosis Kit
(Molecular Probes), with minor modifications, as previously
described (Du et al., 2008). Two cultures of C. albicans were
grown as described in the ‘Determination of endogenous ROS
production’ section, one in the presence of BCO, and the other
in its absence (control).
Toxicological Studies in Mammals
Acute Toxicity
Dermal (according to the guideline OECD 402, U.S. EPA
OPPTS 870.1200) (OECD, 1987; United States Environmental
Protection Agency, 1998a). (2) Eye irritation (according to the
guideline OECD 405, U.S. EPA OPPTS 870.2400) (United States
Environmental Protection Agency, 1998b; OECD, 2002b). (3)
Skin irritation (according to the guideline OECD 404, U.S.
EPA OPPTS 870.2500) (United States Environmental Protection
Agency, 1996; OECD, 2002a). (4) Skin sensitisation (according
to the guideline OECD 406, U.S. EPA OPPTS 870.2600) (OECD,
1992; United States Environmental Protection Agency, 2003).
Short-Term Toxicity
BCO short-term toxicity was investigated in a 22-day topical
dermal toxicity study (guideline OECD 410, 1981) (OECD, 1981).
In Vitro Genotoxicity Testing
(1) Bacterial assay for gene mutation – Ames test (according to
the guideline OECD 471, 1997) (OECD, 1997a). In a reverse gene
mutation assay in bacteria, Salmonella typhimurium histidine-
requiring strains TA98, TA100, TA1535, and TA1537 and
Escherichia coli tryptophan-requiring strain WP2uvrA pKM101
were exposed to BCO. Due to the protein nature of the test
article, the treat and plate methodology was used in preference
to the standard plate-incorporation test, to prevent artifacts
due to growth stimulation following the administration of a
polypeptide-containing test article. (2) Mammalian assay for
gene mutation – mouse lymphoma assay (according to the
guideline OECD 476, 1997, also compliant with OECD 490,
28 July 2015) (OECD, 1997b, 2015). (3) Mammalian assay
for clastogenicity – p53 competent human lymphocyte assay
(according to the guideline OECD 487, 2014) (OECD, 2014a).
BCO was tested in an in vitro micronucleus assay using duplicate
human lymphocyte cultures prepared from blood samples pooled
from two male donors in a single experiment.
In Vivo Studies in Somatic Cells
Comet assay (according to the guideline OECD 489,
2014) (OECD, 2014b). This in vivo alkaline single cell gel
electrophoresis assay, also called alkaline Comet Assay, is a
method to measure DNA strand breaks in eukaryotic cells. Based
on their size, DNA fragments migrate in the gel away from the
head to the tail, and the intensity of the comet tail relative to
the total intensity (head plus tail) reflects the amount of DNA
breakage.
Fluorescence Microscopy
All samples were observed under a fluorescence microscope
(Axioscope A1 with phase contrast and epi-fluorescence, Zeiss)
equipped with a camera (AxioCam ICm1, Zeiss), using three
different filters: Filter Set 49 DAPI (Excitation G 365, Emission
BP 420/470); Filter Set 10 FITC/GFP (Excitation BP 450–490,
Emission BP 515–565); and Filter Set 15 Rhodamine (Excitation
BP 540–552, Emission LP 590).
RESULTS
BCO Effects on C. albicans
Transcriptome and on S. cerevisiae
Mutants
To analyze BCO genome-wide effects and to identify the
mechanisms underlying its fungal growth inhibition (Pinheiro
et al., 2016), RNA-seq was employed to analyze C. albicans
transcriptome upon exposure to BCO for 4 h. A total of 124
genes were found to be differentially expressed. Of these, 80
were up-regulated and 44 were down-regulated comparatively
to untreated yeast cultures. The functional distribution of BCO
responsive genes is shown in Figure 1.
To confirm some of these results, a yeast chemical genetics
approach was carried out using a short list of S. cerevisiae
mutant strains based on their known hypersensitive profiles.
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FIGURE 1 | Assigning Blad-containing oligomer (BCO) responsive genes from Candida albicans to functional categories. The average logarithmic (log2) fold change
ratio from three independent experiments is shown. Genes in boldface have a FDR < 0.05. All other genes have a FDR < 0.1.
FIGURE 2 | Blad-containing oligomer induced growth inhibition in a panel of yeast HIP HOP “signature strains” that are characteristic for common modes of action.
Signature genes were identified previously through high-throughput genome-wide HIP HOP screening of a library of yeast inhibitory small molecules. Growth
inhibition of the 27 strains over 24 h was determined in the presence of a sublethal inhibitory dose of BCO (0.024 µM). Cultures of each strain were diluted to OD600
0.00015 and grown in a 384 well plate with and without BCO. Readings were taken every 20 mins for 27 h to produce 48 separate growth curves. Increase in
growth over 24 h was then used to determine growth inhibition of each strain relative to the untreated control of the same genetic background. The same procedure
was carried out for the isogenic control strain BY4743. Error bars are SEM, n = 12.
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The selected 27 profiles corresponded to 10 common modes
of action described for antifungal drugs (Supplementary Table
S1). Each yeast deletion strain was screened for hypersensitivity
to BCO, as well as the parental strain, using a previously
determined (Supplementary Figure S1) sublethal dose of BCO
(0.024 µM). The results presented in Figure 2 clearly show
that, under these conditions, the only deletion strain displaying
a marked hypersensitivity to the BCO sublethal concentration
corresponded to the mutant lacking the transcription factor Aft1,
a gene involved on iron utilization and homeostasis (Yamaguchi-
lwai et al., 1995).
Neutralization of BCO Activity by
Divalent Cations
Considering the results obtained in the experiments above,
namely the hypersensitivity of the yeast mutant strain
aft11/aft11 and the effect on ion transport/homeostasis
responsive genes, susceptibility tests to BCO were conducted
with C. albicans cells in PDB medium supplemented with six
divalent cations. The following concentrations of each cation
was quantified in the original (unsupplemented) PDB medium:
8 µM Cu2+, 18 µM Ca2+, 59 µM Mg2+, 2 µM Fe2+, 3 µM
Zn2+, and 0.09 µM Mn2+. These concentrations are negligible
compared to the concentrations added and therefore, only the
supplemented concentration was considered for the analysis of
the results (Table 1). Considering the inherent toxicity of each
cation to the cells (Table 1), sub-toxic concentrations were tested
to assess their individual effect on the activity of BCO against
C. albicans. As shown in Table 1, all cations induced a marked
increase in both MIC and MFC values, thus expressing a clear
decrease in the antifungal activity of BCO. Ultimately, albeit
at different concentrations, all cations were able to neutralize
the activity of BCO. The cation potency to neutralize BCO was
lower for magnesium, followed by copper, calcium, and iron.
Manganese and specially zinc were the cations with the strongest
influence on BCO. No differences were found for distinct salts of
the same cation nor between replicates.
BCO Interferes with the Yeast Cell
Membrane Ergosterol Content
The set of genes in the category of lipid, fatty acid, and sterol
metabolism was among the most responsive in the RNA-seq
experiment (Figure 1) and, therefore, the effect of BCO on the
ergosterol content of C. albicans plasma membrane was assessed.
As a positive control, total ergosterol content was also determined
after exposing the cells to FLC. AMB was used as a reference
control for a cell membrane disruption mode of action without
direct interference in the biosynthesis of ergosterol. Caspofungin
was used as negative control. The results (Figure 3) show that
C. albicans suffered a 91% reduction in its ergosterol contact
when exposed to FLC, as compared to the control. This reduction
was significantly lower when the culture was exposed to AMB
(71%) or BCO (69%) whereas caspofungin did not interfere
with the ergosterol content at all. No statistical differences were
observed in the reduction of the ergosterol content between AMB
and BCO.
Induction of C. albicans Apoptosis by
BCO
The third interesting set of responsive genes obtained with
the RNA-seq study was the oxidative stress associated genes
(Figure 1). This gene family has long been associated to cell
apoptosis and previous studies have already shown the induction
of cell death by BCO (Pinheiro et al., 2016). To investigate
whether BCO lethal effect occurs via induction of apoptosis,
and/or necrosis, annexin V and PI staining were performed
(Figure 4). An early marker of apoptosis is the exposure of
phosphatidylserine (PS) on the cell surface, since it is normally
located in the luminal layer of the cytoplasmic membrane (Martin
et al., 1995; Madeo et al., 1997). Annexin V displays a high affinity
for PS and its previous labeling with fluorescein isothiocyanate
(FITC) allows the visual identification of apoptotic cells under
a fluorescence microscope. Staining with PI allows detection of
damaged membranes. Therefore, differential staining patterns
discriminate among live cells (annexin V−/PI−), early apoptosis
(annexin V+/PI−), necrosis (annexin V−/PI+), and late
apoptosis/necrosis (annexin V+/PI+) (Hao et al., 2013). The
majority of C. albicans cells exposed for 4 h to 2.4 µM BCO
were only green in color, which is indicative of early apoptosis
(Figure 4A). Some cells were stained with both dyes, meaning
that, at this point, a minority of cells was undergoing late
apoptosis (Figures 4A,B). Cells grown in the absence of BCO
were not stained by annexin V or PI (data not shown).
ROS Are Produced during BCO Induced
Apoptosis
Production of reactive oxidative species (ROS) by C. albicans
exposed for 4 h to 2.4 µM BCO was analyzed with DCFH-DA,
a non-fluorescent ROS indicator which diffuses across the cell
membrane, undergoes oxidation and emits green fluorescence
(Figure 5). Appropriate controls were cells grown in the absence
of BCO (negative control) and cells exposed to 20 mM H2O2
for 30 min (positive control). After 4 h of incubation with
BCO, ROS accumulation was already detectable in some cells
(Figure 5A). The negative control did not present DCFH-DA
staining, whereas in the positive control 100% cells were stained
(data not shown).
Absence of Topical Toxicity (Acute and
Short Term) and Genotoxicity upon
Exposure of Mammals to BCO (In Vitro
and In Vivo Assays)
Acute Toxicity
No gross signs of clinical toxicity, adverse pharmacologic
effects or abnormal behavior were observed following dermal
(10 rats), eye irritation (3 New Zealand White rabbits),
skin irritation (3 New Zealand White rabbits), and skin
sensitization (20 Guinea pigs). There were also no signs
of toxicity observed at necropsy in all tests. A summary
of the overall results for BCO acute toxicity is shown in
Table 2.
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∗Concentration calculated based only on the added amount of each cation. Each cation was tested independently under two or three different salt formulations (Cu2+:
CuCl2/CuSO4.5H2O; Ca2+: CaCl2.2H2O/CaSO4/Ca(NO3)2; Mg2+: MgCl2.10H2O/MgSO4.7H2O; Fe2+: FeCl2/FeSO4.7H2O; Zn2+: ZnCl2/ZnSO4.7H2O, and Mn2+:
MnCl2.4H2O/MnSO4). There was no variation among triplicates of the MIC and MFC tests.
∗∗ (−) MFC was not determined because there was no well without growth.
Blad-containing oligomer gave rise to non-toxic classification
resulting from rat dermal (LD50 400 mg BCO/kg). Although
the skin and eye irritation studies showed a slightly or mildly
irritating effect, these results were insufficient to warrant
classification according to Annex I of Regulation (EC) No.
1272/2008 (of the European Parliament and of the Council of
16 December 2008 on the classification, labeling and packaging
of substances and mixtures). Furthermore, BCO was not a skin
sensitiser in guinea pig, using the Buehler method.
Short-Term Toxicity
In the 22-day dermal test, no clinical observations of toxicological
importance, no deaths and no clinical signs of toxicity at necropsy
were noted in all groups of rats tested [Crl:WI (Han) rats, 5 sex−1
dose−1].
Genotoxicity Testing
These results are summarized in Table 3.
In Vitro Genotoxicity Testing
Bacterial assay for gene mutation: No evidence for BCO
induced mutagenic activity was detected in the system tested
(three S. typhimurium histidine-requiring strains, and one
E. coli tryptophan-requiring strain) either in the presence
nor in the absence of a rat liver metabolic activation system
(S9). Mammalian assay for gene mutation: In the absence
of the activation system S9, BCO did not induce gene
mutation. In the presence of S9, there was an increase
in mutant frequency (MF) that exceeded the sum of the
Global Evaluation Factor (GEF) + negative control for
the highest concentrations tested. In those cases, increases
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FIGURE 3 | Effect of sub-inhibitory concentrations of BCO, amphotericin B
(AMB), FCL, and caspofungin on the inhibition of ergosterol synthesis in
C. albicans. The results represent the mean ± standard deviation of three
independent experiments. Statistical analysis was performed as described in
the “Materials and Methods” section. Bars with a letter in common are not
significantly different (P > 0.05).
in both small (predominantly) and large colony mutant
frequencies were observed. Under the conditions of this study
the data constituted a positive result in the presence of
S9 and indicated the possibility that the increase in MF
observed is potentially being driven by a clastogenic type
of mechanism. However, the clastogenicity assay performed
in mammalian cells (with cultured human lymphocytes) was
negative.
In Vivo Genotoxicity Testing
Comet assay. There was no dose-related increase in % hedgehogs
in stomach following treatment with BCO, thus demonstrating
that treatment with BCO did not cause excessive DNA damage
(which can interfere with Comet analysis) following oral gavage
administration, nor did mechanical/enzyme-induced damage
result during sample preparation. BCO did not originate
an increase in the incidence of DNA damage, as measured
by % tail intensity in the stomach of male rats (20/dose),
following oral dosing up to a level of 400 mg kg−1 bw
day−1.
FIGURE 5 | Detection of endogenous reactive oxygen species (ROS)
production. DCFH-CA staining of C. albicans cells exposed for 4 h to 2.4 µM
BCO. Cells labeled with DCFH-DA (A) or simply observed by bright field
microscopy (B). Bar corresponds to 10 µm.
TABLE 2 | Summary of acute toxicity of BCO.
Type of study Species Result
Dermal Rat LD50: 400 mg BCO/kg
Skin irritation Rabbit Slightly irritating
Eye irritation Rabbit Mildly irritating
Skin sensitization Guinea pig Non-sensitizing
LD50 – median lethal dose.
DISCUSSION
The limited repertoire of antifungal drugs to treat human fungal
infections, further restrained by increasing events of host toxicity
and drug resistance, has created an urgent and desperate need
for new drugs with novel mechanisms, for both agricultural and
clinical applications. The most up-to-date research for antifungal
drug discovery is focused in alternative treatments with drugs
aimed at novel fungal targets within the cellular circuitry crucial
for stress response (Lamoth et al., 2014), drug resistance (Holmes
et al., 2016), and virulence (Vila et al., 2017), although the classical
research for novel targets aimed at cell survival still prevails
(Balouiri et al., 2016). Here we describe a novel mode of action
of a new, natural and multitarget antifungal compound (BCO)
and assess its toxicity toward mammalian cells.
In a genome-wide analysis of the transcriptome from
C. albicans exposed to BCO, the most representative functional
class of responsive genes included lipid, fatty acid, and sterol
metabolism: three genes involved in sterol biosynthesis
(C3_02820C_A, ERG25, and ERG251) were up-regulated,
FIGURE 4 | Induction of C. albicans apoptosis by BCO. Annexin V and propidium iodide staining of C. albicans cells exposed to 2.4 µM BCO for 4 h. Cells labeled
with annexin V (A), propidium iodide (B), or simply observed by bright field microscopy (C). Bar corresponds to 10 µm.
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TABLE 3 | Summary of genotoxicity testing of BCO.
Type of study Test system Dose range testeda Resulta
In vitro Bacterial (5 strains,
Ames test, treat and plate
methodology)
+/−S9: 3.2–1000 µg/plate ±S9: negative
In vitro Mammalian (L5178Y
TK+/−) gene mutation
Experience 1:
3h –S9: 100–400b µg/mL
3h +S9: 30–180c µg/mL
Experience 2:
3h –S9: 100–500 µg/mL
3h +S9: 60–240 µg/mL
−S9: negative
+S9: positive
In vitro Mammalian (cultured
human lymphocytes)
micronucleus
3 (+21) h +/−S9: 0–400 µg/mL
24 (+24) h –S9: 20–320c µg/mL
±S9: negative
In vivo Rat stomach comet 0, 100, 200, 400 mg/kg bw/day Negative
a S9 from rat liver.
b Higher concentration tested without precipitate at the end of treatment.
c Concentration limited by toxicity.
suggesting a response to ergosterol depletion (Liu et al., 2005),
whereas genes belonging to the lipid (PLB1, INO1, PLB4.5,
RHD1, LKH1, and SAH1) and fatty acid metabolisms (ACH1,
FAS2, CEM1, ACC1, and FAS1) were all down-regulated.
Downregulation of these genes has already been described
in C. albicans after AMB exposure (Liu et al., 2005), and
suggests a disruptive effect of BCO at the cell membrane level
(Spampinato and Leonardi, 2013). Ion transport/homeostasis
seems to play a key role on BCO bioactivity upon C. albicans
cells, as the expression of genes belonging to this class were also
largely affected, particularly those related to zinc homeostasis:
upregulation of CSR1, ZRT1, ZRT2, and PRA1 (Citiulo et al.,
2012; Böttcher et al., 2015). The over-expression of these genes
is induced by mild zinc deficiency (Wu et al., 2008) originated by
its putative sequestration. Zinc is, after magnesium, the second
most widespread metal present in enzymes belonging to all
six major functional classes (Andreini et al., 2008), and zinc
ions are essential for a wide variety of biochemical processes.
Control of zinc homeostasis is especially relevant for pathogens
because the amount of labile zinc in host tissues is very low.
Accordingly, mammals have developed the capacity to inhibit
microbial growth in their tissues by zinc starvation, as part of
a broader defense mechanism termed “nutritional immunity”
(Hood and Skaar, 2012). Besides zinc, both copper and iron
are also required to organisms, primarily through their role as
cofactors in essential metabolic functions (Marvin et al., 2003;
Lan et al., 2004). They were both also affected by BCO: CSA2,
a gene involved in a heme-iron uptake system in C. albicans
(Weissman and Kornitzer, 2004) was up-regulated, which
is in accordance with a low-iron environment, and CTR1, a
copper ion transporter, was also up-regulated, probably due
to its essential role in iron uptake (Lan et al., 2004; Lee et al.,
2005). BCO also seems to impose oxidative stress inside yeast
cells, as upregulation was also observed on four oxidative
stress-related genes: SOD3 and SOD5, AOX2, and PST2 (Liu
et al., 2005; Frohner et al., 2009; Li et al., 2015). This was
corroborated by downregulation of C5-04300C_A gene, a
homolog of S. cerevisiae DUG1 gene, which encodes a glutamine
amidotransferase involved in glutathione catabolism (Toledano
et al., 2013), given that glutathione acts as an important line
of defense against ROS in bio-reductive reactions (Mendoza-
Cózatil et al., 2005). Genes involved in biotin biosynthesis,
namely BIO2, BIO3, and VHT1 (Chattopadhyay et al., 2009)
were also down-regulated upon exposure to BCO. This may
derive from downregulation of genes involved in lipid and fatty
acid metabolisms, because phospholipid precursors play an
essential role in biotin biosynthesis (Santiago and Mamoun,
2003). In addition, biotin synthesis is also repressed under
low-iron conditions (Shakoury-Elizeh et al., 2004). Either way,
this repression in biotin synthesis is most likely a secondary
effect of the exposure to BCO rather than one of its primary
targets. In the same segment are the genes related to nucleic acid
processing, carbohydrate metabolism, protein ubiquitylation,
amino acid metabolism, drug response, and cell growth.
The effect of metal ions on BCO activity was further elucidated
in S. cerevisiae, using HIP HOP profiling with a panel of
gene deletion signature strains. From all the deletion mutant
strains tested, only the homozygous deletion strain aft11/aft11
displayed a marked sensitivity to BCO. AFT1 is a transcription
factor involved in iron utilization and homeostasis (Yamaguchi-
lwai et al., 1995). These results rule out the hypothesis of a
direct effect of metals on the activity or structure of BCO,
and suggest that interference with iron homeostasis and/or
other iron metabolic reactions are involved in BCO mode of
action. Previous results have already demonstrated the metal-
binding activity of BCO in vitro (Supplementary Table S2). It
was demonstrated that in the presence of metallic ions the
melting temperature of BCO shifts in several degrees allowing
to conclude that they are, potentially, strong binding ligands for
BCO. Furthermore, a broader BCO cation scavenging activity
was observed in susceptibility tests against C. albicans, with
a complete neutralization of its antifungal activity by several
divalent cations (zinc, manganese, iron, copper, and calcium).
The alterations in gene expression related to cell membrane
and ergosterol, as well as the previously described destabilizing
effect of BCO on yeast cell membranes (Pinheiro et al., 2016),
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could indicate an interference of BCO with ergosterol synthesis.
This isoprenoid is the main sterol found in fungal and protozoa
cell membranes, and is also the target of many well-known drugs,
including azoles. However, our results seem to indicate that BCO
destabilizes the cell membrane, but not in an ergosterol metabolic
pathway-dependent way. Similarly to other antifungals (Munoz
et al., 2006; Van Der Weerden et al., 2008), this seems to be a
secondary target of BCO, clearly undermining cell stability, but
without an evident effect on cell growth and/or viability per se.
The externalization of PS here demonstrated, combined
with the detection of endogenous ROS production and the
upregulation of oxidative stress response genes upon exposure
of C. albicans to BCO, are consistent with an apoptotic cell
death. The same mechanism has already been described for AMB
(Phillips et al., 2003) and for other antifungals (Wu et al., 2010;
Aerts et al., 2011; Emrick et al., 2013).
Blad-containing oligomer was also thoroughly evaluated in a
range of genotoxicity assays performed both in vitro and in vivo.
Concerns raised over the increase in MF in the mouse lymphoma
assay were not replicated in vitro in either the Ames study (from a
gene mutation mode of action pathway) or in the p53 competent
human lymphocyte assay (from a structural chromosomal mode
of action pathway). Furthermore, the in vivo rat stomach comet
was concluded to be devoid of any DNA damage. Overall,
it may be concluded from the evidence presented here that
BCO is devoid of any genotoxic potential. No carcinogenicity
studies have been conducted because there is no evidence in
the available literature to suggest that proteins similar to BCO,
comprising polypeptide segments of β-conglutin are associated
to an increased incidence of cancer. On the contrary, many
legume seed proteins have been claimed to exhibit anticancer
potential (Quiroga et al., 2015). Therefore, BCO is unlikely to be
considered a carcinogen.
In summary, we demonstrate here that BCO has a disruptive
effect on the cell membrane, allowing its entry into the cell,
but which is not ergosterol-dependent. Similarly to its known
interference with the cell wall (Pinheiro et al., 2016), this does
not seem to be its primary antifungal mode of action. The
available evidence suggests that BCO primary mode of action
is a metal scavenging activity, with a particular effect on zinc
and iron, shattering cell homeostasis. This activity might be
exerted both extra- and intracellularly. An oxidative stress is
then generated inside the cells, culminating in an apoptotic
cell death. BCO showed no evidence of topical toxicity toward
mammalian cells after acute or short-term expositions. The
absence of topical toxicity, genotoxicity, and carcinogenicity
of BCO in mammals is of outmost importance to enable its
potential application to treat topical fungal infections. Moreover,
the metal homeostasis at the host-pathogen interface, which is
BCO’s primary mode of action, is now recognized as a preferential
target for the development of new antifungal drugs, because
metal chelators seem to be beyond drug resistance (Polvi et al.,
2016). Further studies are now required to fully understand
its interaction with fungal cells (namely, its mode of cell
entrance), and with the human body (toxicity and stability after
intravenous administration) in order to determine its potential
for the treatment of systemic fungal infections. Nevertheless,
BCO is already an undoubtedly powerful, novel and very wide-
spectrum tool exhibiting multitarget modes of action, and with
an apparently very low risk for fungal resistance.
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